skip to main content
Idioma:
Refinado por: assunto: Internal Medicine remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Cavo, Michele, Prof ; Tacchetti, Paola, MD ; Patriarca, Francesca, MD ; Petrucci, Maria Teresa, MD ; Pantani, Lucia, MD ; Galli, Monica, MD ; Di Raimondo, Francesco, Prof ; Crippa, Claudia, MD ; Zamagni, Elena, MD ; Palumbo, Antonio, MD ; Offidani, Massimo, MD ; Corradini, Paolo, Prof ; Narni, Franco, MD ; Spadano, Antonio, MD ; Pescosta, Norbert, MD ; Deliliers, Giorgio Lambertenghi, Prof ; Ledda, Antonio, MD ; Cellini, Claudia, MD ; Caravita, Tommaso, MD ; Tosi, Patrizia, MD ; Baccarani, Michele, Prof

The Lancet (British edition), 2010-12, Vol.376 (9758), p.2075-2085 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.